Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes.

OBJECTIVES to examine attitudes of Russian policy-makers and HIV stakeholders towards harm reduction (HR) scale up, focusing on the factors constraining the scale-up process. METHODS Semi-structured interviews with representatives of 58 government and non-governmental organisations involved in HIV policies and programmes in Volgograd Region, Russian Federation. RESULTS We found a considerable diversity of opinion on HR scale-up and suggest that Russia is experiencing the situation of power parity between HR supporters and opponents with many stakeholders being indecisive or cautious to express their views. We identified six main factors which constrain policy decisions in favour of HR scale-up: insufficient financial resources; lack of information on HR effectiveness; perception of HR as being culturally unacceptable; reluctance of IDUs to use the services; opposition from law enforcement agencies and the Russian Church; and unclear legal regulations. We demonstrate a complex interplay between these factors, policy-makers' attitudes and their choices on HR scale-up. CONCLUSIONS A number of actions are needed to achieve a successful scale-up of HR programmes in Russia and similar political contexts: (i) a strategic approach to HR advocacy, targeting neutral and indecisive stakeholders; (ii) more systematic evidence on HR effectiveness and cost-effectiveness in the local context; (iii) HR advocacy targeting law enforcement agencies and the Russian Church; and (iv) aligning best international HR practices with the objectives of local policy-makers, practitioners and service-users.

[1]  J. Twigg.  HIV/AIDS in Russia and Eurasia , 2006 .

[2]  D. D. Jarlais,et al.  HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia , 2002 .

[3]  Sol Levine,et al.  Exchange as a Conceptual Framework for the Study of Interorganizational Relationships , 1961 .

[4]  F. Bastos,et al.  Human immunodeficiency virus, AIDS, and drug consumption in South America and the Caribbean: epidemiological evidence and initiatives to curb the epidemic. , 2005, Revista panamericana de salud publica = Pan American journal of public health.

[5]  M. Field,et al.  From assurance to insurance in Russian health care: the problematic transition. , 1998, American journal of public health.

[6]  J. Lazarus,et al.  HIV/AIDS in Europe: Moving from Death Sentence to Chronic Disease Management , 2006 .

[7]  Diane M. Riley,et al.  Harm Reduction: History, Definition, and Practice , 2000 .

[8]  A. Taket,et al.  Health care reforms in Russia: the example of St Petersburg. , 1995, Social science & medicine.

[9]  W. Parsons,et al.  Public Policy: An Introduction to the Theory and Practice of Policy Analysis , 1996 .

[10]  J. Lazarus,et al.  HIV/AIDS in the transitional countries of Eastern Europe and Central Asia. , 2005, Clinical medicine.

[11]  M. Mckee,et al.  HIV/AIDS in Central Asia , 2006 .

[12]  Michael Hill,et al.  The Policy Process in the Modern Capitalist State , 1984 .

[13]  T. Azim,et al.  Effectiveness of harm reduction programmes for injecting drug users in Dhaka city , 2005, Harm reduction journal.

[14]  T. Rhodes,et al.  HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation , 2004 .

[15]  T. Rhodes,et al.  The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage. , 2004, Addiction.

[16]  D Burrows,et al.  HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. , 1999, Addiction.

[17]  J. Kelly,et al.  The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe , 2003, International journal of STD & AIDS.

[18]  Adrian Renton,et al.  Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. , 2003, Social science & medicine.

[19]  T. Rhodes.  The ‘risk environment’: a framework for understanding and reducing drug-related harm , 2002 .

[20]  D. D. Des Jarlais,et al.  HIV and injecting drug use. , 1993, AIDS & society.

[21]  A. Whiteside,et al.  AIDS in the Twenty-First Century: Disease and Globalization , 2002 .

[22]  D. Silverman,et al.  Ensuring rigour in qualitative research , 1997 .

[23]  M. Fowlkes,et al.  Conceiving Sexuality: Approaches to Sex Research in a Postmodern World.@@@The Sexual Revolution in Russia: From the Age of the Czars to Today. , 1996 .

[24]  N Mays,et al.  Qualitative Research: Rigour and qualitative research , 1995 .

[25]  D. Gibson,et al.  Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. , 2001, AIDS.

[26]  C. Hay.  Political Analysis: A Critical Introduction , 2002 .

[27]  J. Parry,et al.  Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia , 2005, International journal of STD & AIDS.

[28]  M. Aiken,et al.  Organizational interdependence and intra-organizational structure. , 1968 .

[29]  J. Lazarus,et al.  Injecting drug use, harm reduction and HIV/AIDS. , 2006 .

[30]  Samuel A. Macmaster,et al.  HIV Prevention for Active Injection Drug Users , 2002 .

[31]  P. Bacon,et al.  The Primary Prevention of Rheumatic Diseases. , 1995 .

[32]  G. Stimson.  AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. , 1995, Social science & medicine.

[33]  R. Parker,et al.  Change, choice, and conflict in social policy , 1975 .

[34]  Nicholas C. Grassly,et al.  Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India , 2003 .

[35]  M. Mckee,et al.  Public health in Russia: the view from the inside. , 2000, Health policy and planning.

[36]  John W. Kingdon.  Agendas, alternatives, and public policies , 1984 .

[37]  J. Mann,et al.  AIDS in the world. , 1994 .

[38]  P. Das.  XVI International AIDS Conference. , 2006, The Lancet. Infectious diseases.

[39]  Alexander Vlasov,et al.  Street Policing, Injecting Drug Use and Harm Reduction in a Russian City: A Qualitative Study of Police Perspectives , 2006, Journal of Urban Health.

[40]  Joop Koppenjan,et al.  Managing Complex Networks: Strategies for the Public Sector , 1997 .

[41]  Erik-Hans Klijn,et al.  Introduction: A Management Perspective on Policy Networks , 1997 .

[42]  W. Butler.  HIV/AIDS and Drug Misuse in Russia: Harm Reduction Programmes and the Russian Legal System , 2003 .

[43]  D Lee,et al.  The World Health Organisation , 2001, British journal of perioperative nursing : the journal of the National Association of Theatre Nurses.

[44]  Martin McKee,et al.  Analysis of how the health systems context shapes responses to the control of human immunodeficiency virus: case-studies from the Russian Federation. , 2005, Bulletin of the World Health Organization.

[45]  J. Harrison.  Harm reduction: national and international perspectives. , 2000 .

[46]  J. Kaldor,et al.  Effectiveness of needle-exchange programmes for prevention of HIV infection , 1997, The Lancet.

[47]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.